BRIEF-Teva Announces FDA Approval Of Trisenox To Treat Acute Promyelocytic Leukemia

* TEVA ANNOUNCES U.S. FDA APPROVAL OF TRISENOX® (ARSENIC TRIOXIDE) INJECTION FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA